USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Achillion Pharmaceuticals, Inc.
Address:
Achillion Pharmaceuticals, Inc.
300 George St, Ste 801
New Haven, CT 06511 0665
Phone:
(203) 624-7000
URL:
N/A
EIN:
522113479
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $897,665.00 2

Award List:

Capsid assembly inhibitors for the treatment of AIDS

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$597,665.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Current HIV-1 therapy suffers from inadequate viral load suppression due to poor compliance, resistance, and interactions with other drugs and can lead to spread of drug-resistant strains. The current drug cocktails need to include inhibitors of viral components… More

Novel Antibacterial Agents That Target DNA Replication in Mycobacterium tuberculo

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Michael J. Pucci
Abstract:
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (MTB) is probably the most ubiquitous microbial pathogen in the world today infecting one-third of the total population and causing millions of active tuberculosis (TB) cases each year. The ec onomic costs are substantial and more than… More